Cerulean Pharma Inc. Appoints Chief Medical Officer, Edward Garmey, M.D.
5/17/2011 9:42:03 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cerulean Pharma Inc., a leader in designing and developing tumor-targeted nanopharmaceuticals, today announced the appointment of Edward Garmey, M.D., to serve as Chief Medical Officer and Senior Vice President. Dr. Garmey will succeed Dr. John Ryan, who has been named Chairman of the Company’s Medical Advisory Board.
comments powered by